Vasudeo told CNBC-TV18, "Overall the rise has been very good, in fact, almost inching near its historical heights but technically Nectar Lifesciences is trying to get into an overbought zone but it would have the tendency to have spikes further. I think that at higher levels, around Rs 230-243, one can take profits or sell at least part of his holdings at higher levels or alternatively he can maintain a stoploss of around Rs 209. So, whichever higher levels are attained first or stoploss is violated first, whichever is earlier, one can take a call to sell or book profit."
